Neville Kodkani joined Santhera in 2015 as Head Global Marketing in preparation of the launch of Raxone® for LHON in Europe. He was primarily responsible for the development and consecutive execution of the global commercialization strategy for the brand in Europe and select RoW countries. In 2019, he took on operational responsibilities for newly formed Region Central Europe and for multiple commercial partnerships, followed in 2020 by becoming the Interim Head of US Operations. In early 2022, he moved to his current role of VP, Global Marketing and Commercial Partners, where he will be focusing on the development of strategic initiatives related to the commercialization of Santhera’s portfolio across all geographies.
Neville joined Santhera after a long and distinguished career at Roche/Genentech, where he held several commercial roles, both in US and global capacities. During his career, Neville has successfully launched a number of drugs across several geographies, specifically in the areas of oncology, rheumatology and respiratory diseases. Before joining Roche, Neville worked as a physician in Switzerland where he held a number of roles in the clinic and in research.
Neville holds a Medical Degree from the University of Zurich, Switzerland and an MBA from the Kellogg School of Management in Evanston, Ill., in the United States.